Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

OTHER 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

CNS 3Sarcoma 2Other solid neoplasm 1Genitourinary 1Gastrointestinal 1

Conditions

Wilms Tumor 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Pinealoma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Meningeal Neoplasms 1Medulloblastoma 1Hepatoblastoma 1

Interventions

Granulocyte Colony-Stimulating Factor 5Filgrastim 5Etoposide 4Busulfan 4Thiotepa 3Melphalan 3Ifosfamide 3Carboplatin 3Peripheral Blood Stem Cell Transplantation 2Mesna 2sargramostim 1omburtamab I-131 1etoposide phosphate 1entinostat 1becatecarin 1alvocidib 1Ursodeoxycholic Acid 1Thrombopoietin 1Thalidomide 1Tamoxifen 1Stem Cell Transplantation 1Sirolimus 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Paclitaxel 1Leukapheresis 1LY2940680 1Immunologic Techniques 1Fentanyl 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Medulloblastoma × omburtamab I-131 × Other solid neoplasm × Clear all
NCT05064306 2025-08-01

131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

Memorial Sloan Kettering Cancer Center

No longer available
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Medulloblastoma, Meningeal Neoplasms, Wilms Tumor, Neuroblastoma, Pinealoma, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡